B-vitamins intake, DNA-methylation of One Carbon Metabolism and homocysteine pathway genes and myocardial infarction risk: The EPICOR study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 5, 2014, Pages 483-488

  Fiorito, G ^a,b   Guarrera, S ^a   Valle, C ^a   Ricceri, F ^a,b   Russo, A ^a,b   Grioni, S ^c   Mattiello, A ^d   Di Gaetano, C ^a,b   Rosa, F ^a   Modica, F ^a   Iacoviello, L ^e   Frasca, G ^f   Tumino, R ^f   Krogh, V ^c   Panico, S ^d   Vineis, P ^a,g   Sacerdote, C ^a,h   Matullo, G ^a,b  

^a Human Genetics Foundation   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e IRCCS Istituto Neurologico Mediterraneo NEUROMED   (Italy)

^f CIVILE M P AREZZO HOSPITAL   (Italy)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h CPO Piemonte   (Italy)

Author keywords

B vitamins; DNA methylation; Homocysteine; Myocardial infarction; One carbon metabolism

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; ADENOSYLHOMOCYSTEINASE; AMINOMETHYLTRANSFERASE; ARYLDIALKYLPHOSPHATASE 1; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; DIHYDROFOLATE REDUCTASE; FOLATE RECEPTOR 1; FOLATE RECEPTOR 2; GAMMA GLUTAMYL HYDROLASE; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; METHIONINE ADENOSYLTRANSFERASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NICOTINAMIDE METHYLTRANSFERASE; PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE; REPLICATION FACTOR C; THYMIDYLATE SYNTHASE; TRANSCOBALAMIN II; VITAMIN B GROUP; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN; TRANSCOBALAMIN; VITAMIN B COMPLEX;

ADULT; ALGORITHM; ARTICLE; CARBON METABOLISM; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COMPUTER MODEL; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; GENOME ANALYSIS; HEART INFARCTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN INTAKE; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROMOTER REGION; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AMINOMETHYLTRANSFERASE; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; TRANSCOBALAMINS; VITAMIN B COMPLEX;

EID: 84899091135     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.10.026     Document Type: Article

References (25)

1. Allender S., Scarborough P., Peto V., Rayner M., Leal J., Luengo-Fernandez R., et al. European cardiovascular disease statistic 2008 European Heart Network 2008.
2. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012, 33:1635-1701.
3. Greenland P., Alpert J.S., Beller G.A., Benjamin E.J., Budoff M.J., Fayad Z.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice guidelines. Circulation 2010, 122:e584-e636.
4. O'Donnell C.J., Elosua R. Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol 2008, 61:299-310.
5. Lavigne P.M., Karas R.H. The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression. J Am Coll Cardiol 2013, 61:440-446.
6. Finkelstein J.D. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007, 45:1694-1699.
7. Jakubowski H. Pathophysiological consequences of homocysteine excess. J Nutr 2006, 136:1741S-1749S.
8. Jiang Y., Zhang H., Sun T., Wang J., Sun W., Gong H., et al. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice. Acta Biochim Biophys Sin (Shanghai) 2012, 44:866-875.
9. Hubner U., Geisel J., Kirsch S.H., Kruse V., Bodis M., Klein C., et al. Effect of 1 year B and D vitamin supplementation on LINE-1 repetitive element methylation in older subjects. Clin Chem Lab Med 2013, 1-7.
10. Ono H., Iwasaki M., Kuchiba A., Kasuga Y., Yokoyama S., Onuma H., et al. Association of dietary and genetic factors related to one-carbon metabolism with global methylation level of leukocyte DNA. Cancer Sci 2012, 103:2159-2164.
11. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428.
12. Crider K.S., Yang T.P., Berry R.J., Bailey L.B. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr 2012, 3:21-38.
13. Choi S.W., Mason J.B. Folate and carcinogenesis: an integrated scheme. J Nutr 2000, 130:129-132.
14. Riboli E., Kaaks R. The EPIC project: rationale and study design. European prospective investigation into cancer and nutrition. Int J Epidemiol 1997, 26(Suppl. 1):S6-S14.
15. Beard R.S., Bearden S.E. Vascular complications of cystathionine beta-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 2011, 300:H13-H26.
16. Zhao J.Y., Yang X.Y., Shi K.H., Sun S.N., Hou J., Ye Z.Z., et al. A functional variant in the cystathionine beta-synthase gene promoter significantly reduces congenital heart disease susceptibility in a Han Chinese population. Cell Res 2012 Sep 18, [Epub ahead of print]. 10.1038/cr.2012.135.
17. Mackness B., Turkie W., Mackness M. Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease. Arch Med Sci 2013, 9:8-13.
18. Wang M., Lang X., Cui S., Zou L., Cao J., Wang S., et al. Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk. DNA Cell Biol 2012, 31:975-982.
19. Sunder-Plassmann G., Fodinger M. Genetic determinants of the homocysteine level. Kidney Int Suppl 2003, S141-S144.
20. Geisel J., Hubner U., Bodis M., Schorr H., Knapp J.P., Obeid R., et al. The role of genetic factors in the development of hyperhomocysteinemia. Clin Chem Lab Med 2003, 41:1427-1434.
21. Giusti B., Saracini C., Bolli P., Magi A., Martinelli I., Peyvandi F., et al. Early-onset ischaemic stroke: analysis of 58 polymorphisms in 17 genes involved in methionine metabolism. Thromb Haemost 2010, 104:231-242.
22. Kure S., Kato K., Dinopoulos A., Gail C., DeGrauw T.J., Christodoulou J., et al. Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. Hum Mutat 2006, 27:343-352.
23. Narisawa A., Komatsuzaki S., Kikuchi A., Niihori T., Aoki Y., Fujiwara K., et al. Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans. Hum Mol Genet 2012, 21:1496-1503.
24. Marsit C.J., Koestler D.C., Christensen B.C., Karagas M.R., Houseman E.A., Kelsey K.T. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol 2011, 29:1133-1139.
25. Houseman E.A., Christensen B.C., Yeh R.F., Marsit C.J., Karagas M.R., Wrensch M., et al. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 2008, 9:365.